BioXcel Therapeutics Statistics

Total Valuation

BTAI has a market cap or net worth of $6.61 million. The enterprise value is $71.19 million.

Market Cap	6.61M
Enterprise Value	71.19M

Important Dates

The next estimated earnings date is Tuesday, March 11, 2025, before market open.

Earnings Date	Mar 11, 2025
Ex-Dividend Date	n/a

Share Statistics

BTAI has 3.10 million shares outstanding. The number of shares has increased by 24.19% in one year.

Current Share Class	3.10M
Shares Outstanding	3.10M
Shares Change (YoY)	+24.19%
Shares Change (QoQ)	+5.31%
Owned by Insiders (%)	0.97%
Owned by Institutions (%)	9.18%
Float	2.28M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.09
Forward PS	1.98
PB Ratio	-0.08
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	31.28
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.87

Current Ratio	1.87
Quick Ratio	1.58
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-5.11

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-62.12%
Return on Invested Capital (ROIC)	-117.90%
Return on Capital Employed (ROCE)	-318.05%
Revenue Per Employee	$30,757
Profits Per Employee	-$959,405
Employee Count	74
Asset Turnover	0.03
Inventory Turnover	1.14

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -96.21% in the last 52 weeks. The beta is -0.01, so BTAI's price volatility has been lower than the market average.

Beta (5Y)	-0.01
52-Week Price Change	-96.21%
50-Day Moving Average	5.22
200-Day Moving Average	12.98
Relative Strength Index (RSI)	28.65
Average Volume (20 Days)	279,374

Short Selling Information

Short Interest	4.01M
Short Previous Month	1.60M
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	1.37

Income Statement

In the last 12 months, BTAI had revenue of $2.28 million and -$71.00 million in losses. Loss per share was -$31.78.

Revenue	2.28M
Gross Profit	251,000
Operating Income	-74.22M
Pretax Income	-107.83M
Net Income	-71.00M
EBITDA	-73.91M
EBIT	-74.22M
Loss Per Share	-$31.78

Full Income Statement

Balance Sheet

The company has $40.39 million in cash and $104.97 million in debt, giving a net cash position of -$64.58 million or -$20.82 per share.

Cash & Cash Equivalents	40.39M
Total Debt	104.97M
Net Cash	-64.58M
Net Cash Per Share	-$20.82
Equity (Book Value)	-85.63M
Book Value Per Share	-32.27
Working Capital	22.24M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-84.08M
Capital Expenditures	n/a
Free Cash Flow	-84.08M
FCF Per Share	-$27.11

Full Cash Flow Statement

Margins

Gross Margin	11.03%
Operating Margin	-3,260.90%
Pretax Margin	-3,119.33%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

BTAI does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-24.19%
Shareholder Yield	-24.19%
Earnings Yield	-1,074.58%
FCF Yield	-1,272.63%

Analyst Forecast

The average price target for BTAI is $37.00, which is 1,637.09% higher than the current price. The consensus rating is "Buy".

Price Target	$37.00
Price Target Difference	1,637.09%
Analyst Consensus	Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	122.95%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on February 10, 2025. It was a reverse split with a ratio of 0.0625:1.

Last Split Date	Feb 10, 2025
Split Type	Reverse
Split Ratio	0.0625:1

Scores

BTAI has an Altman Z-Score of -22.39 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-22.39
Piotroski F-Score	1